ALMU three-lens brief
Evidence-based stock research on ALMU. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 5% of its 52-week range — deep in the lower band.
- Trading at 5% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 41.3pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $21.00 — 191% above current (3 analysts).
ALMU closed at $7.21 (-1.90%) as of 2026-11-12. Market cap: $139.26M. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $21.00 — 191% above current (3 analysts).. Concerns: trading at 5% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $582.0K, net income -$4.01M, free cash flow -$609.3K. Watching for: 2026-11-12 earnings release (today).
Why three lenses on ALMU, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALMU across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ALMU" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALMU brief"></iframe>